Nephroblastoma Overexpressed (NOV) Peptid
NOV
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle NOV Produkte
- NOV (Nephroblastoma Overexpressed (NOV))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-NOV antibody (Catalog #: ARP43613_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NOV (Nephroblastoma Overexpressed (NOV))
- Synonyme
- CCN3 Peptide, IBP-9 Peptide, IGFBP-9 Peptide, IGFBP9 Peptide, NOVh Peptide, nov-A Peptide, xnov Peptide, NovH Peptide, C130088N23Rik Peptide, nephroblastoma overexpressed Peptide, nephroblastoma overexpressed L homeolog Peptide, nephroblastoma overexpressed gene Peptide, NOV Peptide, nov.L Peptide, Nov Peptide
- Hintergrund
-
As an immediate-early protein, NOV is likely to play a role in cell growth regulation.
Alias Symbols: CCN3, IGFBP9, NOVH
Protein Interaction Partner: CTGF,DLL1,FBLN1,FN1,GJA1,IGF1,IGF2,INS,NOTCH1,POLR2L,S100A4,FBLN1,FN1,IGF1,IGF2,INS,ITGAV,NOTCH1,POLR2L
Protein Size: 357 - Molekulargewicht
- 39 kDa
- Gen-ID
- 4856
- NCBI Accession
- NM_002514, NP_002505
- UniProt
- P48745
-
Sie sind hier:
